Rare diseases
Investigational molecules
Locations
331 conditions with trials, the busiest first
872 trials across Europe, recruiting first
Study on Ruxolitinib for Treating Inclusion Body Myositis in Patients
FranceLong-Term Safety and Efficacy Study of Mexiletine Hydrochloride for Patients with Myotonic Dystrophy Type 1 and Type 2
BelgiumStudy on Upadacitinib for Patients with Idiopathic Inflammatory Myopathies After Stopping IVIG
AustriaStudy of Brigatinib for Children and Young Adults with ALK+ Anaplastic Large Cell Lymphoma, Inflammatory Myofibroblastic Tumors, or Other Solid Tumors
AustriaStudy on the Effectiveness and Safety of Etanercept for Patients with SAPHO Syndrome
PolandEvaluation of nandrolone decanoate treatment combined with physiotherapy and diet in elderly patients with sarcopenia
PolandStudy Comparing Rituximab and KYV-101 for Patients with Active, ACPA-Positive, Treatment-Resistant Rheumatoid Arthritis
GermanyStudy on Colchicine for Patients with Knee or Hip Osteoarthritis
The NetherlandsStudy of Dapansutrile and Paracetamol for Patients with Acute Gout Flare
FranceStudy on the Effectiveness of Phenoxymethylpenicillin Potassium and Amoxicillin for Patients Needing Oral Bone Augmentation
SwedenStudy of Obinutuzumab and Mycophenolate Mofetil Without Oral Corticosteroids for Treatment of Lupus Nephritis
FranceStudy on Ifosfamide and Doxorubicin for Patients with High-Grade Soft Tissue Sarcoma in the Limbs and Trunk Wall
NorwayThe therapies tested most often in Musculoskeletal and connective tissue disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
